Hyperlipidemias: Clinical Trials

700 trials for Hyperlipidemias, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

475 completed, 95 unknown, 51 recruiting, 22 active not recruiting. 700 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable700Completed 475, Unknown 95, Recruiting 51, Active not recruiting 22, Not yet recruiting 19, Terminated 18, Withdrawn 10, Enrolling by invitation 9, Suspended 1

Follow Hyperlipidemias: new trials by email Literature Review of Hyperlipidemias trials Research Report on Hyperlipidemias

Trials (filtered) newest first · largest first

All 700 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Coronary Artery Calcium (CAC) Testing in Primary Care
Our Practice Advisory (OPA) - ASCVD, ASCVD Management
Not applicableNot yet recruitingWeill Medical College of Cornell University202027-02-012026-10-15
Plasma Lipids-Dependent Vitamin E Metabolism During Dynamic Hyperlipidemia
High fat liquid shake - Lipid Metabolism Disorders
Not applicableNot yet recruitingNational Heart, Lung, and Blood Institute (NHLBI)482026-11-182026-11-13
Penn Family Screening for Familial Hypercholesterolemia (NHLBI R33) Trial 3
Cascade Screening - Familial Hypercholesterolemia
Not applicableNot yet recruitingNorthwestern University1102026-11-152026-11-05
Cascade Testing In Identifying At-risk Family Members Of Individuals With Familial Hypercholesterolemia (FH) In PCP
Cascade testing, Standard of Care - Familial Hypercholesterolemia
Not applicableNot yet recruitingMayo Clinic4802026-10-202026-09-18
Metabolic Effects of an Ophiocordyceps Sinensis- and CoQ10-Based Formulation in Mild-to-Moderate Hypercholesterolemia
CORDICOL, Placebo - Hypercholesterolemia, Lipid Metabolism Disorders
Not applicableNot yet recruitingnoiVita Srls1402026-10-192026-10-08
Duke Cardiometabolic Prevention Clinic's Impact on High-risk Cardiovascular Patients With Uncontrolled Risk Factors
Referral to the Duke Cardiometabolic Prevention Clinic - ASCVD, Hyperlipidemia
Not applicableNot yet recruitingDuke University1502026-10-022026-09-08
Comparing Two Low-Carbohydrate Diets With a Standard Diet in Type 2 Diabetes
High-Protein Low-Carbohydrate Diet, High-Fat Low-Carbohydrate Diet, Standard diet - Diabete Mellitus, Obesity & Overweight
Not applicableNot yet recruitingNational Nutrition and Food Technology Institute1682026-09-202026-09-08
Berberol P for Mild-to-Moderate Hypercholesterolaemia
Berberol® P (manufacturer: PharmExtracta S.p.A.), Berberol® K (manufacturer: PharmExtracta S.p.A.) - Hypercholesterolemia
Not applicableNot yet recruitingLiaquat University of Medical & Health Sciences2552026-09-072026-08-27
Standardized Large Yellow Tea Extract for Glucose and Lipid Metabolism in Overweight Adults With Hypertriglyceridemia
Standardized Large Yellow Tea Extract, Placebo - Hypertriglyceridemia, Overweight , Obesity
Not applicableNot yet recruitingThe First Affiliated Hospital of China University of Science and Technology (Anhui Provincial)1382026-09-012026-09-25
Electronic Letters to Improve Patient Activation in IHD: The NUDGE-IHD Trial
LDL-C information letter, Lp(a) information letter - Ischemic Heart Disease, Coronary Artery Disease
Not applicableNot yet recruitingTor Biering-Sørensen1230002026-09-012026-09-08
Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study
Pharmacist-led lipid optimization pathway - ACS (Acute Coronary Syndrome), Hyperlipidemia
Not applicableRecruitingUniversity of Alberta20002026-08-102026-09-09
Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
Moderate-intensity statin and ezetimibe combination therapy, High-intensity statin monotherapy - Renal Insufficiency, Atherosclerosis
Not applicableRecruitingYonsei University19522026-05-282026-06-16
Pemafibrate for Symptomatic ICAS RCT
Pemafibrate - Intracranial Atherosclerotic Disease (ICAD), Hypertriglyceridaemia
Not applicableRecruitingTokyo Women's Medical University2702026-05-262026-11-09
Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors
PC2: Primary Care Connect - Cancer, Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Not applicableEnrolling by invitationRutgers, The State University of New Jersey2662026-04-242026-07-10
Clinical Trial On The Effect Of Artisterol On Risk Factors In Individuals With Suboptimal Cholesterol Levels
investigational product containing phytosterol, artichoke extract and thiamin, Placebo - Hyperlipoproteinemia
Not applicableRecruitingZentiva, k.s.1062026-04-242026-05-12
Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile
corn oil, Avocado Oil - Hypercholesterolemia
Not applicableRecruitingMidwest Center for Metabolic and Cardiovascular Research542026-04-102026-04-17
Virtual Lifestyle Intervention for Weight Management and Cardiovascular Heal
Multicomponent Virtual Lifestyle Intervention - Cardiovascular Risk Factor
Not applicableEnrolling by invitationTruemedicine Inc2002026-04-102026-05-07
WB-EMS Effects on Cardiometabolic Risk Factors
WB-EMS, Control - Hypertension, Metabolic Syndrome
Not applicableActive not recruitingUniversity of Erlangen-Nürnberg Medical School282026-02-152026-05-14
The ORIGIN-FH Study
Screening for FH - Heterozygous Familial Hypercholesterolemia (HeFH), Homozygous Familial Hypercholesterolemia (HoFH)
Not applicableRecruitingUniversity of Wisconsin, Madison702026-02-142026-10-13
New Taipei City 888 Digital Medical AI Platform for Prevention and Care of the Three Highs and Cardio-Renal-Vascular Diseases
Interactive digital modules, Antihypertensive Medication Management - Microalbuminuria, Microalbuminuria /Creatinine Ratios ACR
Not applicableRecruitingNew Taipei City Medical Association41622026-02-052026-05-14

Showing 20 of 700. Sign in to see all of them.

Narrower conditions

Hypercholesterolemia (309)  ·  Hypertension (186)  ·  Diabetes Mellitus (123)  ·  Obesity (116)  ·  Cardiovascular Diseases (92)  ·  Hypertriglyceridemia (89)  ·  Diabetes Mellitus, Type 2 (51)  ·  Metabolic Syndrome (48)  ·  Overweight (48)  ·  Hyperlipoproteinemia Type II (47)  ·  Dyslipidemias (40)  ·  Motor Activity (33)  ·  Hyperglycemia (32)  ·  Inflammation (27)

Broader conditions

Nutritional and Metabolic Diseases (697)  ·  Lipid Metabolism Disorders (692)  ·  Metabolic Diseases (691)  ·  Dyslipidemias (660)  ·  Glucose Metabolism Disorders (228)  ·  Vascular Diseases (228)  ·  Cardiovascular Diseases (197)  ·  Pathological Conditions, Signs and Symptoms (195)  ·  Endocrine System Diseases (173)  ·  Signs and Symptoms (152)  ·  Body Weight (138)  ·  Nutrition Disorders (136)  ·  Overnutrition (134)  ·  Behavior (90)

Interventions

Diet (15)  ·  Exercise (15)  ·  Phytosterols (15)  ·  Simvastatin (11)  ·  Atorvastatin (10)  ·  Diet Therapy (9)  ·  Ezetimibe (7)  ·  Fish Oils (7)  ·  Rosuvastatin Calcium (7)  ·  plant stanol ester (7)  ·  Control Groups (6)  ·  Docosahexaenoic Acids (6)  ·  Nutrition Assessment (6)  ·  Standard of Care (6)  ·  Glucose (5)

Sponsors

University of Bologna (10)  ·  Raisio Group (9)  ·  University of Pennsylvania (9)  ·  Brigham and Women's Hospital (7)  ·  Maastricht University Medical Center (7)  ·  Mayo Clinic (7)  ·  University of Manitoba (7)  ·  Northwestern University (6)  ·  VA Office of Research and Development (6)  ·  Washington University School of Medicine (6)  ·  HealthPartners Institute (5)  ·  Montana State University (5)  ·  Stanford University (5)  ·  University Health Network, Toronto (5)  ·  University of Jena (5)

Countries

United States (261)  ·  Canada (49)  ·  China (28)  ·  Italy (27)  ·  France (22)  ·  Germany (21)  ·  Spain (21)  ·  United Kingdom (19)  ·  Netherlands (15)  ·  Taiwan (15)  ·  Pakistan (14)  ·  South Korea (12)  ·  Denmark (11)  ·  Australia (9)  ·  Norway (8)

Top investigators

Christopher D Gardner (4)  ·  Claudio Borghi, MD (4)  ·  Gerhard Jahreis, Prof. Dr. (4)  ·  Peter Jones, PhD (4)  ·  Benoit Lamarche, PhD (3)  ·  Fernando Civeira, MD, PhD (3)  ·  Hayden B Bosworth, PhD (3)  ·  Jiri Frohlich, MD (3)  ·  Mary P Miles, PhD (3)  ·  Alexander Fanaroff, MD, MHS (2)  ·  Alice H Lichtenstein, D.Sc. (2)  ·  Aline Marcadenti, PhD (2)  ·  Benjamin Druss, MD, MPH (2)  ·  Carla Taylor, PhD (2)  ·  Darshan S Kelley, PhD (2)

Results publications

PMID 25456098, PMID 28487349, PMID 33380172, PMID 12485966, PMID 12620529, PMID 14519406, PMID 14552849, PMID 14679383, PMID 14728353, PMID 14728575, PMID 15247520, PMID 15464042, PMID 15534158, PMID 15791767, PMID 15802479, PMID 16373244, PMID 16522904, PMID 16530201, PMID 16818923, PMID 16843192, PMID 16919541, PMID 16940448, PMID 17101639, PMID 17384344, PMID 17520105, PMID 17521443, PMID 17684201, PMID 17957346, PMID 17998497, PMID 18038131, PMID 18078870, PMID 18156400, PMID 18327998, PMID 18439712, PMID 18541599, PMID 18559131, PMID 18650989, PMID 18754003, PMID 18957532, PMID 18996523, PMID 19081418, PMID 19195513, PMID 19200384, PMID 19369238, PMID 19423109, PMID 19463517, PMID 19528562, PMID 19709787, PMID 19786378, PMID 19889819

NIH funding

2018 (3), 2023 (3), OT2HL158287 (3), 2025 (2), P01HS021141 (2), 7RC4AG039072-02 (1), I01HX003477 (1), K23AR068449 (1), K23HL090505 (1), K24DK068380 (1), M01RR000042 (1), M01RR000400 (1), P01AG018784 (1), P30AG022849 (1), P50MD017342 (1)